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AngII-induced inﬂammation were partly related to TLR4. Cotreatment of CFs with
pioglitazone and AngII revealed no effect on AngII TypeI receptor (AT1), but
downregulated AT1-dependent ERK1/2 phosphorylation. Furthermore, pioglitazone
inhibited AngII-induced MCP-1 and TNF-a production and overexpression of TLR4,
Myd88 and NF-kB; and increased nuclear-PPARg production in CFs.
Conclusions: These results suggest that TLR4 is involved in the AngII-induced in-
ﬂammatory responses in CFs, and pioglitzone provides its anti-inﬂammatory and
antiﬁbrotic effect which is partly depend on interfering with the TLR4-dependent
signaling pathway (AT1/ERK1/2/TLR4/Myd88/NF-kB) to prevent the hypertension
induced ventricle remodeling.
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Objectives: We studied the characteristics of ambulatory blood pressure (ABP) and
their inﬂuence factors in healthy Chinese children.
Methods: Casual blood pressure (BP), ABP, body height, weight, body mass index
(BMI), personal and familial medical histories were recorded in 338 Chinese children
(aged 5-12 years). Data were treated by ABP database system and analyzed by SPSS
20.0 including correlations, regressions and conventional statistical methods.
Results: Means of 24-Hour SBP/DBP/PP (systolic BP/diastolic BP/pulse pressure)
were 112.710.2/66.35.7/46.67.3 and 110.98.1/66.55.1/44.66.0 mmHg in
normal weight 118 boys and 139 girls, and were 118.311.3/67.96.5/50.78.7 and
113.621.4/65.712.2/48.111.5 mmHg in overweight 46 boys and 35 girls,
respectively. BMI, weight and gender were primary inﬂuencing factors on ABP-
derived parameters. Overweight children had higher means (P<.01 or <.05) of sys-
tolic BP (SBP) and pulse pressure (PP), and higher hypertensive prevalence (35% vs.
15% for boys and 40% vs. 18% for girls) than normal weight children. Boys had
higher (P <.01) means of PP (24-Hour /Daytime) than girls in normal weight children.
Age related negatively with DBP and body height correlated with heart rate. Circadian
variations of ABP (dipper pattern) were seen in most of children (76%). Familial
histories of hypertension showed no inﬂuence on ABP.
Conclusions: BMI, weight and gender were the main inﬂuencing factors on ABP
in Chinese children and our data provides basic information of ABP in Chinese
children.
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Objectives: The aim of this study was to investigate the effect of the human adipo-
nectin (Hapm1) gene-modiﬁed stromal vascular fraction (SVF) cells (Hapm1-SVF)
transplantation on the cardiac function and histological changes of heart tissue in rats
with myocardial infarction.
Methods: Rats were divided into four groups (n¼8) : sham-operated (sham), un-
treated myocardial infarction (MI), SVF treated (SVF), and HapM1-SVF (SVF car-
rying human adiponectin gene and labeled with EGFP) treated (HapM1-SVF) groups.
The MI model was established by ligation of the left anterior descending coronary
arteries. SVF were injected into the infracted border zone of MI rats. EF and FS were
detected by echocardiography 4 weeks after the cells transplantation. LVSP and
LVDP were measured by PowerLab biological signal analytical system. Vascular
density was determined by immunohistochemical staining.
Results: It was shown that LVSP and LVDP were signiﬁcantly increased in MI rats
treated with SVF cells or HapM1 gene-modiﬁed SVF cells as compared with untreated
MI rats, but still not reach the normal level [LVSP: sham (99.357.45) VS MI
(72.835.37) VS SVF (77.857.82) VS Hapm1-SVF (84.238.65) mmHg, P<0.05].
EF and FS of rats in HapM1-SVF or SVF groups were signiﬁcantly higher than that of
MI rats, but still not reach the normal level (EF: sham (81.854.63%) VS MI
(43.213.10%) VS SVF (64.934.13%) VS Hapm1-SVF (74.563.60%), P<0.05).
Meanwhile, the density of vessels in HapM1-SVF group was higher than that in SVF
or MI group, but still lower than that in sham group.
Conclusions: In summary, transplantation of SVF cells carrying hapM1 gene may
stimulate recovery of cardiac function after myocardial infarction in rats.
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Objectives: Klotho (KL) is a recently discovered aging-suppressing gene. Insertional
mutation of KL gene resulted in a premature aging syndrome. Overexpression of KLC14 JACC Vol 64/16/Suppl C j Octobgene extended the lifespan by 20% and rescued other aging disorders. Hypertension
and kidney damage are common aging-related diseases. The purpose of this study is to
assess if KL deﬁciency affects blood pressure (BP) and renal damage as well as the
underlying mechanism.
Methods: One group of heterozygous mutant KL (KL (+/-) ) mice and one group of
wild type (WT) mice were used to measure BP continuously when they were from the
age of 8 months to 13 months. Each strain of mice was further divided into 2 sub-
groups when the mice were at the age of 15 months, which received eplerenone
treatment (6 mg/kg/day, IP) or an equal dose vehicle, respectively. BP was measured
and urine was collected during treatment. At the end of the treatment for 3 weeks, the
animals were sacriﬁced and blood was collected. Plasma aldosterone level was
detected with an aldosterone ELISA kit. Kidney sections were used for periodic acid
Schiff staining, Masson’s trichrome staining and immunohistochemical staining (CD4,
CD8, and CD68). Adrenal sections were used for immunohistochemical staining
(klotho, CYP11B2). Plasma urea and creatinine level were detected with quanti-
chromTM assay kits. Urinary albumin concentration was measured with a micro-
albuminuria ELISA kit. Western blotting was done to detect the expression of MR,
SGK1, NCC, and ATP synthase b, TNF-a, MCP-1, IL-6 and osteopontin in kidney.
Results: The results demonstrated that the systolic BP was signiﬁcantly and persis-
tently elevated accompanied by aldosterone level increase and CYP11B2 (key enzyme
of aldosterone synthesis) upregulation in KL (+/-) mice. Chronic treatment with
eplerenone (aldosterone receptor blocker) decreased hypertension to the control level
and prevented the upregulation of SGK1, NCC and ATP synthase b level in kidneys
of KL (+/-) mice, suggesting that KL deﬁciency causes hypertension due to plasma
aldosterone increase and the subsequent renal sodium retention through SGK1-NCC
signaling. Moreover, signiﬁcant renal structure damage (glomerulus collapse, tubule
ﬁbrosis) and function decline (plasma creatinine, urea and urine albumin increase)
were observed in KL (+/-) mice. Further analysis indicated that several proin-
ﬂammatory cytokines (TNFa, MCP-1, IL-6 and osteopontin) were upregulated and
leucocyte (T cell and macrophage) inﬁltration were increased in kidneys of KL (+/-)
mice. Eplerenone rescued KL deﬁciency-induced kidney damage and abolished the
activated inﬂammatory process.
Conclusions: KL is essential to the maintenance of normal BP. KL deﬁciency caused
hypertension and kidney damage via upregulating aldosterone level and consequently
increasing inﬂammation and SGK1-NCC signaling in kidneys.
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Objectives: Cellular repressor of E1A-stimulated genes (CREG) has been proposed to be
a new cardiovascular homeostasis regulator. We hypothesized that CREG is a negative
regulator of angiotensin (Ang) II-mediated hypertension and vascular remodeling.
Methods: Ten-week-old male heterozygous CREG-deﬁcient (CREG+/-) mice and
their littermate wild-type (WT) mice were implanted with osmotic minipumps con-
taining saline, Ang II (1.5 mg/kg$d), or Ang II and recombinant human CREG
(rhCREG; 15-300 mg/kg$d) protein for 14 days. Ang II-infused CREG+/- mice were
then cotreated with p38 MAPK inhibitor, SB203580 (10 mg/kg$d), beginning 2 days
before minipump implantation. Systolic blood pressure (SBP); extent of vascular
remodeling; RNA and protein level of CREG, collagen type I/III, angiotensin-con-
verting enzyme-2 (ACE2), angiotensin receptor type 1 (AT1R), Ets-1 and MAPK
were evaluated. Primary vascular smooth muscle cell (VSMC) culture was performed
to assess the mechanism of Ang II-induced CREG down-regulation, as well as CREG-
mediated modulation of renin-angiotensin system.
Results: CREG levels are high in vascular media under basal conditions but rapidly
decrease in response to Ang II. Ets-1 transcription factor expression is upregulated in
Ang II-stimulated VSMCs. Chromatin immunoprecipitation analysis showed the
interaction of endogenous and exogenous Ets-1 or glutathione S-transferase-tagged
Ets-1, bearing only the DNA-binding domain with the authentic CREG promoter.
Moreover, Ets-1 siRNA knockdown signiﬁcantly reduced Ang II-induced repression
of CREG expression, indicating Ets-1 mediates Ang II-induced down-regulation of
CREG expression. Ang II infusion for 14 days resulted that levels of SBP, intima
medial thickness and vascular remodeling of the aorta and mesenteric artery were
signiﬁcantly greater in CREG+/- mice compared with the WT controls. Vascular gene
expression level of CREG was lower in Ang II-treated CREG+/- mice than in WT
mice, suggesting that CREG deﬁciency aggravates Ang II-induced hypertension and
vascular remodeling. However, daily treatment of Ang II-infused WT mice with
rhCREG protein improved the above phenotypes. Ang II-induced vascular remodeling
was inhibited by rhCREG protein in association with reduced plasma Ang II and
increased plasma Ang 1-7 levels. Furthermore, rhCREG treatment inhibited Ang II-
mediated up-regulation of AT1R expression and down-regulation of ACE2 expression
by blocking p38MAPK activation. Finally, pharmacological blockade of p38MAPK
with SB203580 abolished CREG deﬁciency mediated the aggravation of Ang II-
induced hypertension and vascular remodeling.
Conclusions: Ets-1 mediates Ang II-induced down-regulation of CREG expression.
Elevated Ang II induced hypertension and vascular remodeling, which were exac-
erbated by CREG deﬁciency, whereas rhCREG protein attenuated Ang II-induced
hypertension and vascular remodeling through modulation of balance betweener 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
